Clinical Trials Browser

Phase 1/2 × INDUSTRY × Imiquimod × Clear all

NCT02078648 2025-02-03

Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme

Phase 1/2 Completed

74 enrolled 19 charts

Glioblastoma

NCT02224599 2020-04-24

Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies

Phase 1/2 Terminated

3 enrolled 6 charts

Neoplasms

NCT00785122 2013-05-16

IMA910-101

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms